Pseudomonas XY-1 and application thereof in acetic acid production through carbon dioxide reduction

By discovering and applying Pseudomonas XY-1, this strain efficiently reduces carbon dioxide to acetic acid at the optimal ferrous concentration, solving the problem of low carbon dioxide reduction efficiency in the prior art and achieving efficient CO2 conversion and the production of valuable chemicals has important energy and environmental application value.

CN118956687AActive Publication Date: 2024-11-15ZHEJIANG UNIV OF TECH
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
CN202411307527.9
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-19
Publication Date
2024-11-15
Estimated Expiration
2044-09-19

AI Technical Summary

Technical Problem

The prior art is difficult to effectively utilize carbon dioxide for reduction, and biological methods have limited applications in reducing greenhouse gas emissions, especially in efficient conversion of carbon dioxide into beneficial substances.

Method used

A new strain of Pseudomonas XY-1 was discovered and provided, which can efficiently reduce carbon dioxide to acetic acid under the optimal ferrous concentration conditions and achieve CO2 in inorganic salt culture medium through specific culture methods. Reduction includes the addition of sodium 2-bromoethanesulfonate and high purity CO2 at pH 6-8 and incubation at 30-35°C.

Benefits of technology

The maximum accumulation of CO2 reduction in acetic acid produced by Pseudomonas XY-1 at the optimal ferrous concentration reached 73.11 mg/L, demonstrating significant CO2 reduction ability, and is easy to expand and cultivate in the growth environment, with important energy. and environmental significance.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118956687A_ABST
    Figure CN118956687A_ABST
Patent Text Reader

Abstract

The invention discloses pseudomonas XY-1 and application of the pseudomonas XY-1 in acetic acid production through carbon dioxide reduction. The pseudomonas can reduce CO2 into acetic acid. The application comprises the following steps: inoculating the pseudomonas XY-1 into an inorganic salt culture solution which has the pH value of 6-8 and is aerated to be saturated by CO2 gas, and culturing at the temperature of 30-35 DEG C to realize reduction of CO2. The highest cumulant of the pseudomonas XY-1 for reducing CO2 to produce acetic acid under the optimal ferrous concentration (0 mg / L) can reach 73.11 mg / L. Therefore, the pseudomonas has a certain reducing capacity on CO2, realizes conversion of CO2 into renewable chemicals, and is beneficial to alleviation of energy crisis.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to a strain of Pseudomonas (Pseudomonas) XY-1 and application thereof in producing acetic acid by reducing carbon dioxide. Background Art

[0002] Global warming is one of the most serious challenges facing mankind today. The large-scale emission of greenhouse gases has accelerated the rise in global temperatures. In 2023, global energy-related carbon dioxide emissions increased by 1.1%, an increase of 410 million tons, reaching a historical high of 37.4 billion tons. The sources of CO2 in the atmosphere include: the combustion of fossil fuels (coal, oil, natural gas); the production and processing of coal, oil, etc.; animal respiration and feces; plant respiration and humic acid fermentation; organic matter (animals, plants) fermentation and decay process; volcanic eruptions, forest fires, etc. Reducing greenhouse gas emissions and achieving carbon neutrality and carbon peak targets are efforts made by mankind in the face of the climate change crisis. Its main task is to target the carbon dioxide generated in human production and life, mainly to study the entire process of carbon dioxide emission, capture, utilization, storage and removal and related technical systems (CCUS technology). These include photocatalysis, electrocatalysis, thermal catalysis, radiolysis, etc., but they all require additional energy consumption. Compared with them, biological methods are greener and milder, and have broader application prospects.

[0003] A moderate amount of carbon dioxide can benefit mankind, but when the carbon dioxide content in the air reaches 1%, it is harmful to humans; when it reaches 4-5%, it will cause people to feel shortness of breath, headaches, and dizziness; when it reaches 10%, it can make people unconscious, breathing gradually stops, and even die. Carbon dioxide is one of the main driving forces of the earth's greenhouse effect. It can absorb heat from the earth and prevent it from being lost to space. When the concentration of carbon dioxide continues to increase, it will cause the earth's energy balance to be unbalanced, and then trigger global climate change, causing an increase in extreme weather events; reduce the nutritional value and insect resistance of crops, increase the reproduction of pests, and endanger agricultural production; cause damage to the marine ecosystem and affect the survival of marine life.

[0004] Therefore, it is very necessary to study the utilization of CO2 in the environment and convert it into other beneficial substances for human health. Through literature search, no reports on the reduction of CO2 by Pseudomonas using CO2 as the only carbon source were found. The maximum cumulative amount of acetic acid produced by CO2 reduction of Pseudomonas XY-1 of the present invention is as high as 73.11 mg / L under the condition of the optimal ferrous iron concentration (10 mg / L), and the growth environment is mild and easy to expand and cultivate. The discovery of this strain is of great significance for CO2 reduction and alleviating the energy crisis. Summary of the invention

[0005] The purpose of the present invention is to provide a new strain, Pseudomonas XY-1, and its application in acetic acid production by CO2 reduction.

[0006] The technical solution of the present invention is:

[0007] The present invention provides a new strain - Pseudomonas XY-1, which is deposited in China Center for Type Culture Collection, with a deposit number of CCTCC NO: M20241326, a deposit date of June 20, 2024, and an address of Wuhan University, Wuhan, China, 430072.

[0008] The basic characteristics of the Pseudomonas XY-1 of the present invention are: the colony is light yellow, has neat edges, is opaque, smooth and moist, and is easy to pick up. The bacterial body is observed under a field emission scanning electron microscope to be a rod-shaped bacillus without flagella and a size of 500×3600nm.

[0009] The present invention also provides an application of the Pseudomonas XY-1 in acetic acid production by CO2 reduction. Specifically, the application is to inoculate the Pseudomonas XY-1 into an inorganic salt culture solution with a pH of 6-8 (preferably 7), add sodium 2-bromoethane sulfonate, and introduce high-purity CO2 into the inorganic salt culture solution until the solution is saturated, and culture the solution at 30-35°C (preferably 30°C) and 100-300rpm (preferably 160rpm) to achieve CO2 reduction.

[0010] Furthermore, the Pseudomonas XY-1 is added in the form of resting cells, and an appropriate amount of resting cells is added to the inorganic salt culture solution.

[0011] The contents of the components in the inorganic salt culture solution are as follows: Na2HPO4·12H2O45-47g / L; NH4Cl 1.2-1.3g / L; NaH2PO4·H2O 9.3-10.3g / L; KCl 0.45-0.55g / L; mineral mother liquor 12.2-12.7mL / L; vitamin diluent 4-6mL / L; deionized water, the remainder. The dosage ratio of the sodium 2-bromoethane sulfonate to the inorganic salt culture solution is 0.8-1.2g:1L. The contents of the components in the mineral mother liquor are as follows: nitrilotriacetic acid NTA 1.2-1.7 g / L; MgSO4 2-4 g / L; MnSO4·H2O 0.4-0.6 g / L; NaCl 0.8-1.2 g / L; FeSO4·7H2O 0.08-0.12 g / L; CaCl2·2H2O 0.08-0.12 g / L; CoCl2·6H2O 0.08-0.12 g / L; ZnCl2 0.1-0.15 g / L; CuSO4·5H2O 0.008-0.012 g / L; AlK(SO4)2·12H2O 0.008-0.012 g / L; H3BO3 0.008-0.012 g / L; Na2MoO4 0.02~0.027g / L; NiCl2·6H2O 0.02~0.027g / L; Na2WO4·2H2O 0.02~0.027g / L; balance deionized water. The contents of the components in the vitamin diluent are as follows: vitamin VH 0.0015-0.0025 g / L; folic acid VB 0.0015-0.0025 g / L; pyridoxine hydrochloride 0.008-0.012 g / L; riboflavin 0.0045-0.0055 g / L; thiamine VBI 0.0045-0.0055 g / L; niacin 0.0045-0.0055 g / L; pantothenic acid VB5 0.0045-0.0055 g / L; vitamin B-12 0.00008-0.00012 g / L; p-aminobenzoic acid 0.0045-0.0055 g / L; lipoic acid 0.0045-0.0055 g / L; deionized water, the remainder.Further, the inorganic salt culture solution is composed of: Na2HPO4·12H2O 46.165g / L, NH4Cl1.25g / L, NaH2PO4·H2O 9.808g / L, KCl 0.52g / L, trace mineral mother solution 12.5mL / L, trace vitamin diluent 5mL / L, pH 6-8, and the solvent is deionized water; wherein the trace mineral mother solution is composed of: NTA 1.5g / L, MgSO4 3g / L, MnSO4·H2O 0.5g / L, NaCl 1g / L, FeSO4·7H2O 0.1g / L, CaCl2·2H2O 0.1g / L, CoCl2·6H2O0.1g / L, ZnCl2 0.13g / L, CuSO4·5H2O0.01g / L, AlK(SO4)2·12H2O 0.01g / L, H3BO3 0.01g / L, Na2MoO4 0.025g / L, NiCl2·6H2O 0.024g / L, Na2WO4·2H2O 0.025g / L, the solvent is deionized water; wherein the trace vitamin diluent is obtained by diluting the trace vitamin mother solution 100 times, and the composition of the trace vitamin mother solution is: vitamin VH 0.2g / L, folic acid VB 0.2g / L, pyridoxine hydrochloride 1g / L, riboflavin, vitamin Br 0.5g / L, thiamine VBI 0.5g / L, niacin 0.5g / L, pantothenic acid VB5 0.5g / L, B-12 0.01g / L, p-aminobenzoic acid 0.5g / L, lipoic acid 0.5g / L, and the solvent is deionized water.

[0012] Furthermore, the Pseudomonas XY-1 is inoculated in the form of resting cells, and the resting cells are prepared according to the following steps:

[0013] (1) Shake flask screening: Take 10 mL of the mixed strain and place it in an inorganic salt culture medium. Add 1 g / L of sodium 2-bromoethane sulfonate and pass high-purity CO2 into the inorganic salt culture until the solution is saturated. After acclimatization and culture for 2-3 weeks, spread it on an inorganic salt plate using the dilution coating method. The inorganic salt plate composition is the same as the above-mentioned inorganic salt culture medium and 15-20 g / L agar. After 4-5 times of the above operation, a single colony appears on the solid plate.

[0014] (2) Slant culture: The strain was inoculated into a slant LB solid medium and cultured at 30°C for 24-36 h to obtain slant bacteria. The final concentration of the LB solid medium was as follows: NaCl 10 g / L, tryptone 10 g / L, yeast powder 5 g / L, agar 15-20 g / L, the solvent was deionized water, and the pH was natural.

[0015] (3) Expansion culture: inoculate the slant cells from step (1) into LB liquid culture medium using an inoculation loop, culture at 30° C. and 160 rpm for 24-36 h to obtain expansion culture solution, centrifuge, collect wet cells, wash with inorganic salt culture solution, and obtain resting cells of the strain; LB liquid culture medium composition: 5 g / L yeast powder, 10 g / L NaCl, 10 g / L peptone, natural pH, and the solvent is deionized water.

[0016] Compared with the prior art, the present invention has the following beneficial effects:

[0017] The strain provided by the present invention is taken from sewage plant sludge, and the strain can reduce CO2 to acetic acid, and under the condition of optimal ferrous iron concentration (10 mg / L), the maximum cumulative amount of acetic acid produced by reducing CO2 can reach 73.11 mg / L. Therefore, the Pseudomonas has a certain reduction ability for CO2 and can produce valuable chemicals (acetic acid). BRIEF DESCRIPTION OF THE DRAWINGS

[0018] Figure 1 This is a photo of the colony morphology of Pseudomonas XY-1 on LB medium.

[0019] Figure 2 Field emission scanning electron microscopy images of Pseudomonas XY-1 (×10000 and ×20000).

[0020] Figure 3 This is the phylogenetic tree of Pseudomonas XY-1.

[0021] Figure 4 This is a graph showing the accumulation of acetate when Pseudomonas XY-1 uses CO2 as the carbon source.

[0022] Figure 5 This is a graph showing the accumulation of acetic acid when Pseudomonas XY-1 uses sodium bicarbonate as the carbon source.

[0023] Figure 6 Pseudomonas XY-1 in different concentrations of ferrous ions (Fe 2+ ) under the conditions of acetic acid accumulation. DETAILED DESCRIPTION

[0024] The present invention is further described below in conjunction with specific embodiments, but the protection scope of the present invention is not limited thereto:

[0025] Unless otherwise specified, the materials and reagents used in the following examples can be obtained from commercial sources.

[0026] The inorganic salt culture medium is composed of: Na2HPO4·12H2O 46.165g / L, NH4Cl 1.25g / L, NaH2PO4·H2O 9.808g / L, KCl 0.52g / L, trace mineral mother solution 12.5mL / L, trace vitamin diluent 5mL / L, pH 6-8, and the solvent is deionized water; wherein the trace mineral mother solution is composed of: NTA 1.5g / L, MgSO4 3g / L, MnSO4·H2O 0.5g / L, NaCl 1g / L, FeSO4·7H2O 0.1g / L, CaCl2·2H2O 0.1g / L, CoCl2·6H2O 0.1g / L, ZnCl2 0.13g / L, CuSO4·5H2O0.01g / L, AlK(SO4)2·12H2O 0.01g / L, H3BO3 0.01g / L, Na2MoO4 0.025g / L, NiCl2·6H2O 0.024g / L, Na2WO4·2H2O 0.025g / L, and the solvent is deionized water; wherein the trace vitamin diluent is obtained by diluting the trace vitamin mother solution 100 times, and the composition of the trace vitamin mother solution: vitamin VH 0.2g / L, folic acid VB0.2g / L, pyridoxine hydrochloride 1g / L, riboflavin, vitamin Br 0.5g / L, thiamine VBI 0.5g / L, niacin 0.5g / L, pantothenic acid VB5 0.5g / L, B-12 0.01g / L, p-aminobenzoic acid 0.5g / L, lipoic acid 0.5g / L, and the solvent is deionized water.

[0027] LB solid culture medium composition: yeast powder 5g / L, NaCl 10g / L, peptone 10g / L, agar 15-20g / L, natural pH, solvent is deionized water.

[0028] LB liquid culture medium composition: yeast powder 5g / L, NaCl 10g / L, peptone 10g / L, pH natural, solvent is deionized water.

[0029] Example 1: Isolation, purification and identification of strain Pseudomonas XY-1.

[0030] 1. Isolation and purification of strain Pseudomonas XY-1.

[0031] The strain Pseudomonas XY-1 is a Gram-negative bacterium domesticated and isolated from activated sludge. The specific steps are as follows:

[0032] Add 90mL of inorganic salt culture medium to a 300mL serum bottle, add 10mL of bacterial solution obtained from a laboratory reactor, then add 1g / L of sodium 2-bromoethane sulfonate and pass high-purity CO2 until the solution is saturated. Place the above serum bottle in a shaker at 30°C and 160rpm for enrichment culture, and monitor its acetic acid accumulation with a gas chromatograph. When the acetic acid accumulation begins to decrease, transfer the 10mL bacterial solution in the serum bottle to the next serum bottle and add fresh inorganic salt culture medium, 1g / L sodium 2-bromoethane sulfonate and pass high-purity CO2 until the solution is saturated. Repeat the above process 4-5 times, and then dilute the last bacterial solution with sterile water in a gradient manner and apply it on LB solid culture medium, culture at 30°C, select single colonies, and purify by streaking on LB plates ( Figure 1 The obtained single colony was inoculated into an inorganic salt culture medium serum bottle, and high-purity CO2 was introduced until the solution was saturated. CO2 was used as the only carbon source for verification (a blank control was set up, one with only CO2 as the carbon source and one without CO2, for comparison. In the serum bottle containing CO2, the microorganisms grew well, and the serum bottle without CO2 was clear and no microorganisms grew). The strain XY-1 was screened and its morphology was determined by field emission scanning electron microscopy ( Figure 2 ).

[0033] 2. Identification of strain XY-1

[0034] (1) Characteristics of strain XY-1: The colony is light yellow, with neat edges, opaque, smooth and moist, and easy to pick up. The morphology of the bacteria observed under a field emission scanning electron microscope is coryneform, with a size of 500×3600nm.

[0035] (2) The strain was identified as Pseudomonas by 16S rRNA sequence analysis and physiological and biochemical experiments. The specific steps are as follows:

[0036] The DNA of the strain was extracted and purified using the Ezup column bacterial genomic DNA extraction kit and stored at 4°C. The purified DNA was amplified by PCR using universal bacterial primers, 27F (AGAGTTTGATCCTGGCTCAG) and 1492R (GGTTACCTTGTTACGACTT), and the PCR reaction program was set to 95°C pre-denaturation for 5 min, then 95°C denaturation for 30 s, 56°C annealing for 30 s, 72°C extension for 90 s, 25 cycles, and finally 72°C repair extension for 10 min. The PCR product was purified and recovered and sequenced (Shanghai Meiji Biopharmaceutical Technology Co., Ltd.). The sequencing results of 16S rRNA (shown in SEQ ID NO.1) were uploaded to NCBI and obtained the accession number MK346044. At the same time, the sequence was compared with the gene sequence in the NCBI database by Blast. It was found to belong to the genus Pseudomonas and had 99% homology with Pseudomonas koreensis strain DP24, Pseudomonas moraviensis strain cqsm g2, Pseudomonas sp. CS-MA1 and Pseudomonas koreensis strain Cr13. Twelve representative strains of Pseudomonas were selected from the results and a phylogenetic tree was constructed using MEGA7.0 software based on the homology of 16S rRNA gene sequences, as shown in the following figure. Figure 3 By comparing genetic distance and 16S rRNA sequence, strain XY-1 was identified as Pseudomonas. The base sequence of DNA of strain XY-1 is shown in SEQ ID NO.1.

[0037] Example 2: Study on the reduction of acetic acid by Pseudomonas XY-1 using sodium bicarbonate as a carbon source

[0038] The resting cells were prepared according to the following steps: (1) Shake flask screening: 10 mL of mixed strains were placed in an inorganic salt culture medium, and 1 g / L of sodium 2-bromoethane sulfonate was added to the inorganic salt culture medium and high-purity CO2 was introduced until the solution was saturated. After acclimation and culture for 2-3 weeks, the diluted coating method was used to coat the solution on an inorganic salt plate. The inorganic salt plate composition was the same as the above-mentioned inorganic salt culture medium and 15 g / L agar. After 4 times of the above operation, a single colony appeared on the solid plate. (2) Slant culture: The strain was inoculated into a slant LB solid culture medium and cultured at 30°C for 24 hours to obtain slant bacteria. The final concentration of the LB solid culture medium was: NaCl 10 g / L, tryptone 10 g / L, yeast powder 5 g / L, agar 15 g / L, the solvent was deionized water, and the pH was natural. (3) Expansion culture: Inoculate the slant cells from step (2) into LB liquid culture medium with an inoculation loop, culture at 30°C, 160 rpm for 24 h to obtain expansion culture solution, centrifuge, collect wet cells, wash with inorganic salt culture solution, and obtain resting cells of the strain; LB liquid culture medium composition: 5 g / L yeast powder, 10 g / L NaCl, 10 g / L peptone, natural pH, solvent is deionized water. Add the resting cells into 100 mL of inorganic salt culture solution (Fe 2+ : 2mg / L) serum bottle, and add 1g / L of 2-bromoethanesulfonic acid sodium and 2g / L of sodium bicarbonate, place the serum bottle in a shaker at 30°C and 160rpm, and take samples at regular intervals to detect the amount of acetic acid accumulation. The results are as follows Figure 5 As shown, it can be seen that when sodium bicarbonate is used as the carbon source, the maximum acetic acid accumulation of the strain is 31.74 mg / L, which is lower than the yield when CO2 is used as the carbon source under the same conditions ( Figure 4 ).

[0039] Example 3: Study on the ability of Pseudomonas XY-1 to reduce CO2 to produce acetic acid at different ferrous ion concentrations

[0040] The ferrous ions (Fe 2+ ) concentration is 2mg / L, and the concentration of ferrous ions in the inorganic salt culture medium is increased by adding an appropriate amount of ferrous sulfate to 100mL of the inorganic salt culture medium, wherein the concentration of ferrous ions in each group of inorganic salt culture medium is 2mg / L, 4mg / L, 10mg / L, and 50mg / L, respectively, and 1g / L of sodium 2-bromoethane sulfonate is added to each group of inorganic salts, and high-purity CO2 is introduced until the solution is saturated with an appropriate amount of bacteria, and the serum bottle containing the above substances is placed in a shaker at 30°C and 160rpm for culture, and samples are taken at intervals to detect the amount of acetic acid accumulation. The results are as follows Figure 6As shown, it can be seen that when the concentration of ferrous ions is not greater than 10 mg / L, the maximum accumulation of acetic acid increases with the increase of the concentration of ferrous ions. However, when the concentration of ferrous ions is 50 mg / L, there is a significant inhibitory effect, and the maximum accumulation of acetic acid is significantly reduced to only 9.86 mg / L.

[0041] Although the present invention has been disclosed as above by the embodiments, it is not intended to limit the protection scope of the present invention. Any changes and modifications made by any technician familiar with the technology without departing from the concept and scope of the present invention should fall within the protection scope of the present invention.

Claims

1. A Pseudomonas XY-1, characterized in that It is deposited in China Center for Type Culture Collection with the accession number CCTCCNO:M20241326.

2. Use of Pseudomonas XY-1 as claimed in claim 1 in acetic acid production by carbon dioxide reduction.

3. The use according to claim 2, characterized in that Specifically include: The resting cells obtained by culturing Pseudomonas XY-1 are added to an inorganic salt culture solution with a pH of 6-8, and sodium 2-bromoethane sulfonate is added at the same time. CO2 is introduced into the inorganic salt culture solution to saturate the solution, and acetic acid is synthesized by carbon dioxide reduction.

4. The use according to claim 2, characterized in that The contents of the components in the inorganic salt culture solution are as follows:

5. The use according to claim 2, characterized in that The dosage ratio of the sodium 2-bromoethane sulfonate to the inorganic salt culture solution is 0.8-1.2 g:1L.

6. The use according to claim 4, characterized in that The contents of the components in the mineral mother liquor are as follows:

7. The use according to claim 4, characterized in that The contents of the components in the vitamin diluent are as follows:

8. The use according to claim 3, characterized in that The Pseudomonas XY-1 is cultured to obtain resting cells, specifically comprising: (1) Slant culture: Inoculate Pseudomonas XY-1 onto a plate with LB solid medium and culture at 30-35°C to obtain slant cells; (2) Expansion culture: inoculate the slant cells from step (1) into LB liquid culture medium, culture at 30-35°C and 100-300 rpm for 24-36 hours to obtain expansion culture medium, centrifuge, collect wet cells, wash with inorganic salt culture medium, and obtain resting cells of Pseudomonas XY-1.

9. The use according to claim 3, characterized in that The acetic acid was synthesized by carbon dioxide reduction at 30-35°C and 100-300rpm.

Citation Information

Patent Citations

  • Pseudomonas monteilii SD-2 and application thereof in degradation of organic pollutants

    CN116463254A

  • Nitrate reducing pseudomonas ZKJ and application thereof in degradation of organic pollutants

    CN116731923A

  • Pseudomonas sp. and a preparation method and application of bifunctional enzyme preparation of pseudomonas sp.

    US20190376153A1

  • Pseudomonas balearica and application thereof in treating landfill leachate membrane concentrated solution

    WO2021077452A1